Connect with us

Technology

RelaxPLX® Gains Health Canada License, and South Korean Sleep Quality Support Claim

Published

on

The health claims will help drive collaboration with leading international supplement brands

MADRID, June 24, 2026 /PRNewswire/ — Monteloeder, SL, a subsidiary of SUANNUTRA SA, announces RelaxPLX® has officially received individual license approval for its sleep quality support by the Ministry of Food and Drug Safety (MFDS) of South Korea. In addition, this lemon verbena formulation attained a Health Canada Product License for multiple sleep and stress claims.

“Attaining these health claims is an important regulatory milestone for RelaxPLX in North America and Asia Pacific,” exclaims Stephanie Guillén-Díaz, Chief Commercial Officer for SUANNUTRA. “This strengthens the ingredient’s credibility and provides a valuable platform for business development with Canadian, South Korean and international partners.”

Health Canada claims

The Health Canada Product License gives RelaxPLX an authorized claim framework in one of the world’s most established and respected supplement markets. The approved Canadian claims are closely aligned with RelaxPLX®’s core clinical evidence and commercial positioning:

Helps improve sleep quality.Helps improve symptoms of sleep disturbance and thereby promotes sleep quality.Temporarily relieves symptoms of perceived stress.Helps reduce cortisol, a biomarker of physical stress.Helps improve sleep quality in adolescents with stress.Helps improve sleep quality in individuals with symptoms of mild anxiety.

“These claims differentiate RelaxPLX positioning because they combine two highly relevant consumer concerns: sleep quality and stress-related wellbeing,” explains Guillén Díaz. “They go beyond a common sleep-quality claim by connecting sleep with some of the most relevant factors affecting consumers today. This is exactly what brands are looking for.”

The science behind RelaxPLX®

RelaxPLX® is supported by three dedicated randomized, placebo-controlled clinical studies focused on sleep and stress-related outcomes. These studies were conducted across different populations, including adults with sleep and stress concerns, adults with sleep disturbances, and adolescents experiencing mild sleep and stress-related challenges.

“These studies provide strong backing for RelaxPLX’s® efficacy, showing that its clinical story is not based only on subjective consumer perception,” says Daniel González-Hedström, PhD, R&D Director for SUANNUTRA. “They combined validated questionnaires, objective sleep assessment, and physiological markers while addressing benefits that consumers can clearly understand—better sleep quality, stress-related balance, and feeling more restored in everyday life.”

Individual license approval by the MFDS of South Korea 

The MFDS is recognized as one of the world’s most rigorous authorities when it comes to bioactive ingredient approvals. The process to obtain individual license recognition in South Korea required a long-term commitment. It was a demanding, multi-stage project from dossier preparation through to final recognition. The objective was to demonstrate that a daily intake of 400mg/day of RelaxPLX’s® lemon verbena (Aloysia citrodora) extract may help to improve sleep quality.

To obtain this status, an ingredient must be clearly characterized, consistently manufactured, safe for human consumption, and supported by scientific evidence for the proposed functionality. The Korean authority evaluates the ingredient’s identity, origin, manufacturing process, quality specifications, active or marker compounds, analytical methods, stability, safety, and clinical trial evidence.

SUANNUTRA’s experts prepared a detailed documentation on the botanical source, extraction process, standardization, analytical profile, quality controls, product specifications, physiological markers in specific studies, and safety data in addition to clinical substantiation. Attention was focused on demonstrating that the ingredient submitted for recognition was consistent with the ingredient used in the clinical studies. SUANNUTRA worked in close collaboration with COSMAX BIO, whose local expertise was essential in navigating the Korean Health Functional Food framework.

“The individual license permits Korean brands using RelaxPLX to label their products with a sleep quality support claim,” explains Mariana Ortega, Science Marketing Manager for SUANNUTRA. “This achievement represents a significant step forward for SUANNUTRA, not only in the South Korean market but also in many countries in Asia Pacific.”

Visible Health Platform

SUANNUTRA designed the Visible Health Platform, a strategic framework to translate clinical science into tangible benefits that consumers can understand and integrate into their everyday lives. One of the three categories is the Visible Balance platform. Sleep quality and stress balance are benefits people can experience in their daily rhythm: waking up more restored, feeling more balanced and better managing occasional stress.

As part of Visible Balance RelaxPLX® helps address two of the most important pillars of everyday wellbeing: restorative sleep and healthy stress management. This makes RelaxPLX® especially attractive for brands seeking to develop next-generation products that are not only science-backed, but also emotionally attractive and practically relevant to consumers.

Company contact

Press Contact

Monteloeder, S.L., a subsidiary of SuanNutra 

NutriPR

Mariana Ortega

Science Marketing Manager

Liat Simha

Tel: +972-9-9742893

E-mail: info@monteloeder.com

E-mail: liat@nutripr.com

Website: www.suannutra.com

Twitter: @NutriPR_

Website: www.nutripr.com

Photo – https://mma.prnewswire.com/media/2999031/RelaxPLX.jpg

 

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/relaxplx-gains-health-canada-license-and-south-korean-sleep-quality-support-claim-302809186.html

SOURCE Monteloeder, S.L.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

ClaimAngel and SmartAdvocate Launch The First One Click Legal Funding Experience For Plaintiff Firms

Published

on

By

Integration gives all SmartAdvocate firms one workflow for plaintiff funding, case updates, and live payoffs, with access to multiple vetted funders and ClaimAngel’s 27.8% simple annual rate capped at 2x.

BOCA RATON, Fla., June 25, 2026 /PRNewswire/ — ClaimAngel today announced the launch of its integration with SmartAdvocate, the case management platform used by more than 20,000 legal professionals nationwide.

Consumer legal funding has always carried practical and ethical tensions: clients need money to get by while their case is pending, and firms need a funding process they can trust, explain, and monitor. The problem with the funding industry has always been its exorbitant rates and archaic processes.

That changes now. This first-of-its-kind integration breaks that decades-old mold by bringing legal funding directly into SmartAdvocate, allowing firms to digitally request funding, track case updates, and manage live payoffs. This integration simplifies the entire funding process and promotes a seamless experience for law firms.

“Funding should help lawyers to maximize their client’s recovery, it should be efficient, ethical and affordable,” said Jeremy Alters, CEO of ClaimAngel. “ClaimAngel gives firms a transparent, standardized process they can trust: multiple vetted funders, the lowest set rate in the industry, and every request, update, and payoff tracked inside the case file.”

“We’re pleased to welcome ClaimAngel as a SmartAdvocate integration partner. We are committed to providing law firms with access to innovative, trusted technology solutions that enhance the way they serve their clients. This integration expands the options available to firms by connecting ClaimAngel’s funding platform directly within SmartAdvocate, helping firms manage key case-related activities from a single platform.” – Allison Rampolla, SVP of Sales & Marketing, SmartAdvocate

Since launching in 2023, ClaimAngel has facilitated more than $130 million across more than 27,000 fundings for over 700 law firms in more than 40 states. ClaimAngel is now available to all SmartAdvocate firms. ClaimAngel is listed in the SmartAdvocate integration partner directory under Funding.

About ClaimAngel

ClaimAngel is the standard and infrastructure consumer legal funding has been missing: a set rate, a marketplace, and embedded workflows inside the systems plaintiff firms already use. ClaimAngel operates a transparent marketplace where more than 25 vetted funders compete at a 27.8% simple rate, capped at 2x, and owed only if the case succeeds. Learn more at https://claimangel.com.

About SmartAdvocate

SmartAdvocate is a fully customizable, award-winning case management software used by more than 20,000 legal professionals.The platform helps attorneys and legal staff manage cases, documents, communications, reporting, and firm operations in a single, unified system. SmartAdvocate’s innovation strategy is built-in SmartIntelligence™AI-powered features that help firms improve intake, automate document-intensive processes, enhance communications, and gain deeper insight from case data. With more than 175 integrations, SmartAdvocate combines innovative technology with personal support to help law firms operate more efficiently and achieve stronger outcomes.

For more information visit https://www.smartadvocate.com/.

View original content to download multimedia:https://www.prnewswire.com/news-releases/claimangel-and-smartadvocate-launch-the-first-one-click-legal-funding-experience-for-plaintiff-firms-302810996.html

SOURCE ClaimAngel

Continue Reading

Technology

From boots to bookings: Mastercard insights show where Calgary Stampede drives meaningful lift for local businesses

Published

on

By

The Mastercard Economics Institute shows restaurants, retail and accommodations are among the biggest beneficiaries.

CALGARY, AB, June 25, 2026 /CNW/ – New insights from the Mastercard Economics Institute (MEI) show the Calgary Stampede does more than draw crowds, it sets Calgary’s economy in motion even before the gates open, from last-minute retail runs ahead of opening weekend to surging restaurant demand and early hotel bookings downtown.

Using aggregated and anonymized spending insights from 2025, alongside travel trends through bookings made by the end of May 2026 with departure dates from June 29 through July 12 for Calgary International Airport, MEI examined how economic activity around the Calgary Stampede compared with expected baseline levels without the event.

MEI estimates that the 2025 Calgary Stampede generated an approximate 18 per cent lift in spending at local merchants relative to baseline, with restaurants experiencing one of the strongest lifts at roughly 29 per cent. Retail spending also surged ahead of opening weekend, while accommodation demand built early, especially in downtown Calgary.

The data reveals a clear pattern: Stampede’s economic impact builds in waves. Retail spending jumps before the festivities begin, as Calgarians and visitors prepare for the week ahead. Dining demand remains elevated through the event, and accommodation spend is front-loaded into the first few days as visitors arrive and settle in. Together, the insights show that Stampede is not just busy, it is an engine of local spending in ways that are visible across time, place and category.

The spending story is also being shaped by international interest in Stampede. Preliminary booking data suggests international travel tied to Stampede is up year over year in 2026, with some of the strongest international growth coming from the United States, Belgium, the Netherlands, Great Britain and Australia.

“The Calgary Stampede is a great example of how a cultural moment can also be a major economic catalyst,” said Benjamin Jacob, Senior Vice President, Services, Mastercard, Canada. “For local businesses, success during Stampede is not just about being busy, it is about being ready. Insights like these can help businesses better anticipate demand and make smarter decisions around staffing and inventory during one of Calgary’s most important economic moments.”

“While the Calgary Stampede is a cultural and recreational highlight for our city, it is also a key opportunity to showcase Calgary on the global stage. The 10-day event reflects the energy, entrepreneurial spirit and community pride that defines Calgary, while attracting visitors from around the world,” said Melanie McDonald, Vice President, Strategic Initiatives, Partnerships and Engagement, Calgary Chamber of Commerce. “Generating an estimated $664 million in economic activity in Calgary in 2025, the Stampede provides a significant boost to restaurants, bars, hotels, entertainment venues, coffee shops, retailers and many other local businesses across the city. It is also a time when Calgary’s business community comes together to strengthen relationships and celebrate the spirit of collaboration that supports the city’s continued growth.”

The insights show how Stampede spending unfolds across the city:

MEI estimates that the 2025 Calgary Stampede drove a roughly 18 per cent lift in overall spending at local merchants relative to expected baseline without the event.Restaurants saw some of the strongest lift in spend, approximately 29 per cent, underscoring the role dining plays in the Stampede experience.Retail spending surged on the Thursday ahead of opening weekend, as consumers prepared for Stampede festivities.Accommodation demand built early, with the strongest lift concentrated downtown in the first few days of the event.Among international markets tied to Stampede travel in 2026, the United States accounts for roughly one-third of all bookings.Travel bookings are up year over year from international markets, including the Netherlands, Belgium, Great Britain and Australia.  

The insights also show that economic value is not evenly distributed. Spending patterns varied by sector, location and timing, with some of the strongest lifts concentrated in areas closest to the Stampede grounds and in experience-led categories such as dining and accommodations.

As businesses navigate a more complex economic environment, understanding those patterns matters. Through the Mastercard Economics Institute and its economic solutions, Mastercard helps businesses, governments and partners decode what is happening in the real economy using anonymized spending insights to help them plan with greater confidence and act on emerging opportunities.

About Mastercard (NYSE: MA)

Mastercard powers economies and empowers people in 200+ countries and territories worldwide. Together with our customers, we’re building a resilient economy where everyone can prosper. We support a wide range of digital payments choices, making transactions secure, simple, smart and accessible. Our technology and innovation, partnerships and networks combine to deliver a unique set of products and services that help people, businesses and governments realize their greatest potential.

SOURCE Mastercard Canada

Continue Reading

Technology

Days After Launch, Attunio Health Expands Precision Psychiatry Infrastructure with Quest Diagnostics and Getlabs

Published

on

By

Quest Diagnostics and Getlabs strengthen Attunio’s AI-powered, biomarker-driven infrastructure with blood and genetic testing from home

ATLANTA, June 25, 2026 /PRNewswire/ — Just days after publicly launching its AI-powered precision psychiatry platform and gaining early media attention, Attunio Health announced a major expansion of its clinical infrastructure by selecting Quest Diagnostics as its national laboratory backbone and integrating Getlabs for at-home blood collection.

The announcement marks another significant milestone in Attunio’s rapid growth as the company builds what it believes is the future of mental healthcare: continuous, objective, data-driven care powered by artificial intelligence, biomarkers, and real-world patient signals.

While traditional psychiatry has long relied on subjective symptom reporting, episodic visits, and trial-and-error medication management, Attunio is building a fundamentally different model.

The firm’s system merges:

Clinical insights provided through artificial intelligence.

Physiological information collected by devices worn on the human body.

Examination of blood biomarkers

Examination of genetic material.

The observation of behavior.

Medical professional-directed therapy enhancement.

This infrastructure powers what Attunio calls Closed-Loop Precision Psychiatry™ — a model in which psychiatric treatment is continuously informed by evolving biological and behavioral data rather than limited to occasional appointments.

With Quest Diagnostics serving as Attunio’s national laboratory backbone, the platform can support scalable access to advanced diagnostic testing across the United States.

These diagnostic capabilities help clinicians identify biological contributors to mental health impairment, including:

Impaired metabolic function

Persistent inflammation

Lack of essential vitamins and nutrients.

A state of disrupted hormonal equilibrium.

Drug processing and indicators of safety.

Measures of neurobiological performance

Attunio has also integrated Getlabs to enable blood and genetic testing from home, allowing certified mobile phlebotomists to travel directly to patients’ homes or workplaces for specimen collection.

This dramatically reduces friction in diagnostic testing and makes biomarker-driven psychiatric care more accessible to patients nationwide.

By combining diagnostic testing with wearable data and AI analysis, Attunio aims to help clinicians answer critical questions traditional psychiatric visits often cannot:

Is declining focus caused by ADHD progression or poor sleep?

Is worsening anxiety linked to physiological stress or metabolic dysfunction?

Is medication underperforming due to biology, genetics, or adherence?

Can deterioration be detected before a patient reaches crisis?

As interest accelerates around AI in healthcare, digital biomarkers, and precision medicine, Attunio is positioning itself at the intersection of psychiatry, diagnostics, and artificial intelligence.

The company believes mental healthcare must evolve beyond reactive care.

The future, Attunio says, will be:

Predictive. Measurable. Personalized.

This latest infrastructure expansion builds on Attunio’s recent launch, which introduced a new model of behavioral healthcare centered on wearable data, biomarker analysis, and AI-powered clinical intelligence designed to improve outcomes for conditions such as ADHD, anxiety, depression, and cognitive burnout.

About Attunio Health

“Attunio Health is deeply committed to advancing health and wellness, striving to deliver innovative solutions that make a tangible difference in people’s lives every day. Our dedication extends beyond mere treatment, focusing on proactive care and fostering healthier communities across the region and beyond.” To learn more visit https://www.attuniohealth.com/marketplace

View original content to download multimedia:https://www.prnewswire.com/news-releases/days-after-launch-attunio-health-expands-precision-psychiatry-infrastructure-with-quest-diagnostics-and-getlabs-302811003.html

SOURCE Attunio Health

Continue Reading

Trending